Mechanistic investigations revealed that cerebral ischemia–reperfusion upregulated the mRNA and protein expression of gp91phox, the catalytic subunit of NADPH oxidase, whereas NBO treatment markedly suppressed this upregulation and diminished NADPH oxidase activity, thereby attenuating ROS generation. Here, FMO5 is linked to brain ischemia.